Literature DB >> 15222032

Effect of vector-expressed siRNA on HBV replication in hepatoblastoma cells.

Jun Liu1, Ying Guo, Cai-Fang Xue, Ying-Hui Li, Yu-Xiao Huang, Jin Ding, Wei-Dong Gong, Ya Zhao.   

Abstract

AIM: To study the effect of siRNA expressed from DNA vector on HBV replication.
METHODS: Human U6 promoter was amplified from genomic DNA and cloned into plasmid pUC18 to construct a mammalian siRNA expression vector pUC18U6. Then oligonucleotides coding for a short hairpin RNA against HBV were cloned into pUC18U6 to form pUC18U6HBVsir which was introduced into 2.2.15 cells by using liposome-mediated transfection. 2.2.15 cells transfected by pUC18U6 and pUC18U6GFPsir which expressed siRNA against green fluorescent protein and mock-transfected 2.2.15 cells were used as controls. Concentration of HBsAg in the supernatant of the transfected cells was measured by using solid-phase radioimmunoassay.
RESULTS: A mammalian siRNA expression vector pUC18U6 was constructed successfully. Compared with controls, pUC18U6HBVsir which expressed siRNA against HBV decreased concentration of HBsAg significantly by 44%(P<0.05).
CONCLUSION: HBV replication in 2.2.15 cells is inhibited by siRNA expressed from the DNA vector.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15222032      PMCID: PMC4572226          DOI: 10.3748/wjg.v10.i13.1898

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

1.  Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells.

Authors:  Patrick J Paddison; Amy A Caudy; Emily Bernstein; Gregory J Hannon; Douglas S Conklin
Journal:  Genes Dev       Date:  2002-04-15       Impact factor: 11.361

2.  A DNA vector-based RNAi technology to suppress gene expression in mammalian cells.

Authors:  Guangchao Sui; Christina Soohoo; El Bachir Affar; Frédérique Gay; Yujiang Shi; William C Forrester; Yang Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

Review 3.  Management of chronic hepatitis B.

Authors:  Hari S Conjeevaram; Anna Suk-Fong Lok
Journal:  J Hepatol       Date:  2003       Impact factor: 25.083

Review 4.  RNA interference.

Authors:  Gregory J Hannon
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

5.  Short interfering RNA confers intracellular antiviral immunity in human cells.

Authors:  Leonid Gitlin; Sveta Karelsky; Raul Andino
Journal:  Nature       Date:  2002-06-26       Impact factor: 49.962

6.  Inhibition of hepatitis B virus replication by stably expressed shRNA.

Authors:  Ying Chen; Dan Du; Jun Wu; Chun-Pong Chan; Yuequi Tan; Hsiang-fu Kung; Ming-Liang He
Journal:  Biochem Biophys Res Commun       Date:  2003-11-14       Impact factor: 3.575

7.  Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells.

Authors:  Nan Sook Lee; Taikoh Dohjima; Gerhard Bauer; Haitang Li; Ming-Jie Li; Ali Ehsani; Paul Salvaterra; John Rossi
Journal:  Nat Biotechnol       Date:  2002-05       Impact factor: 54.908

8.  Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes.

Authors:  Kaveh Ashrafi; Francesca Y Chang; Jennifer L Watts; Andrew G Fraser; Ravi S Kamath; Julie Ahringer; Gary Ruvkun
Journal:  Nature       Date:  2003-01-16       Impact factor: 49.962

9.  Selective inhibition of hepatitis B virus replication by RNA interference.

Authors:  Chunxiao Ying; Erik De Clercq; Johan Neyts
Journal:  Biochem Biophys Res Commun       Date:  2003-09-19       Impact factor: 3.575

10.  siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells.

Authors:  Karin Butz; Tutik Ristriani; Arnd Hengstermann; Claudia Denk; Martin Scheffner; Felix Hoppe-Seyler
Journal:  Oncogene       Date:  2003-09-04       Impact factor: 9.867

View more
  3 in total

1.  Two approaches to construct mammalian expression vector of shRNA to reduce expression and replication of HBV in vitro.

Authors:  Hong-Bin Zhang; Jie Wu; Jiang Xian; Lei Pei; Jie Wang
Journal:  Mol Biol Rep       Date:  2007-06-22       Impact factor: 2.316

2.  Vector design for liver-specific expression of multiple interfering RNAs that target hepatitis B virus transcripts.

Authors:  Lindsey L Snyder; Jonathan M Esser; Catherine J Pachuk; Laura F Steel
Journal:  Antiviral Res       Date:  2008-05-06       Impact factor: 5.970

Review 3.  RNAi for treating hepatitis B viral infection.

Authors:  Yong Chen; Guofeng Cheng; Ram I Mahato
Journal:  Pharm Res       Date:  2007-12-12       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.